[ pharmacokinetic and pharmacodynamic aspects of l-dopa treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in parkinson 's disease ( author 's transl ) ] .
C0023570
l-dopa
C0030567
parkinson 's disease